SEC filings
Merck & Co. (MRK)
Recent filings Merck & Co. made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0000310158All filings on SEC.gov
10-QQuarterly report
Quarterly report
Merck & Co. reported third-quarter 2026 worldwide sales of $18.1 billion, up 5% from a year earlier, and detailed 2026 business development activity including the $9.2 billion acquisition of Cidara Therapeutics, the $6.8 billion…
8-KCurrent report
Results of Operations and Financial Condition
Merck & Co. reported third-quarter 2026 worldwide sales of $18.1 billion, up 5%, with GAAP EPS of $2.04 and non-GAAP EPS of $2.49, and narrowed and raised the midpoint of its full-year 2026 sales and non-GAAP EPS guidance. …
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Merck & Co. announced that Paul J. Diaz, a managing partner at Cressey & Company, will join its board of directors effective Nov. 1, 2026, and will stand for election by shareholders in May 2027, bringing the board to 14 members. …
10-QQuarterly report
Quarterly report
Merck & Co. reported worldwide sales of $16.6 billion for the second quarter of 2026 and $32.9 billion for the first six months, both up 5% year over year, and detailed 2026 acquisitions of TARGAN for about $650 million, Terns…
8-KCurrent report
Results of Operations and Financial Condition
Merck & Co. reported second-quarter 2026 worldwide sales of $16.6 billion, up 5% from a year earlier, with a GAAP loss per share of $0.54 reflecting a $2.31-per-share charge for the acquisition of Terns Pharmaceuticals; …
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Merck & Co. in Readster
Add Merck & Co. to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.